Recently, Noorani et al. explored the role of EGFR mutants in IDH1 wild-type gliomas through whole-exome sequencing, transcriptomics and transposon mutagenesis forward genetic screening, and found new putative tumor suppressors [8]. Here, IDH1 is linked to central nervous system cancer.